by Medical Xpress August 24, 2017
"Three large trials published today in Diabetologia (the journal of the European Association for the Study of Diabetes) show that screening for type 2 diabetes and cardiovascular risk factors may not reduce mortality and cardiovascular disease in the general population. However, for individuals diagnosed with diabetes, screening is associated with a reduction in mortality and cardiovascular disease risk. " full text
Articles mentioned in this news:
- Simmons (2017). Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults
- Simmons (2017). Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009
- Feldman (2017). Screening for type 2 diabetes: do screen-detected cases fare better?
- Simmons (2017). Should we screen for type 2 diabetes among asymptomatic individuals? Yes
- Shaw (2017). Does the evidence support population-wide screening for type 2 diabetes? No